Search research articles
Contact Us
Filters
Showing results (141-150 of 183) with videos related to
Page
of 19
Sort By:
Psychopharmacology
|
September 28, 2007
Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana
Aviv Weinstein, Orit Brickner, Hedva Lerman, et al.
Frontiers in Pharmacology
|
September 4, 2023
Endocannabinoid basis of personality-Insights from animal model of social behavior
Natalya M Kogan, Dilorom Begmatova, Liudmila Vinnikova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2015
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici, et al.
The Journal of Biological Chemistry
|
March 13, 2008
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis
Javier Palazuelos, Nathalie Davoust, Boris Julien, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 28, 2022
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia
Isadora Lopes Cortez, Nicole R Silva, Naielly S Rodrigues, et al.
British Journal of Pharmacology
|
January 26, 2020
An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain
Yong Fang Zhu, Katja Linher-Melville, Mohammad Javad Niazmand, et al.
British Journal of Pharmacology
|
April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Brain Research
|
March 17, 2011
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
Athanasios Lourbopoulos, Nikolaos Grigoriadis, Roza Lagoudaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone mass
Orr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 9, 2022
HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism
Idan Carmon, Lital Zecharyahu, Jinan Elayyan, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 183) with videos related to
Sort By:
Page
of 19
Psychopharmacology
|
September 28, 2007
Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana
Aviv Weinstein, Orit Brickner, Hedva Lerman, et al.
Frontiers in Pharmacology
|
September 4, 2023
Endocannabinoid basis of personality-Insights from animal model of social behavior
Natalya M Kogan, Dilorom Begmatova, Liudmila Vinnikova, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2015
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici, et al.
The Journal of Biological Chemistry
|
March 13, 2008
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis
Javier Palazuelos, Nathalie Davoust, Boris Julien, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 28, 2022
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia
Isadora Lopes Cortez, Nicole R Silva, Naielly S Rodrigues, et al.
British Journal of Pharmacology
|
January 26, 2020
An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain
Yong Fang Zhu, Katja Linher-Melville, Mohammad Javad Niazmand, et al.
British Journal of Pharmacology
|
April 1, 2011
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bėla Horváth, Lital Magid, Partha Mukhopadhyay, et al.
Brain Research
|
March 17, 2011
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
Athanasios Lourbopoulos, Nikolaos Grigoriadis, Roza Lagoudaki, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone mass
Orr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 9, 2022
HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism
Idan Carmon, Lital Zecharyahu, Jinan Elayyan, et al.
Page
of 19